ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

LLOY Lloyds Banking Group Plc

50.92
-0.08 (-0.16%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Lloyds Banking Group Plc LSE:LLOY London Ordinary Share GB0008706128 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.08 -0.16% 50.92 50.86 50.90 51.08 50.20 50.70 115,482,629 16:35:22
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Commercial Banks, Nec 23.74B 5.46B 0.0859 5.92 32.33B
Lloyds Banking Group Plc is listed in the Commercial Banks sector of the London Stock Exchange with ticker LLOY. The last closing price for Lloyds Banking was 51p. Over the last year, Lloyds Banking shares have traded in a share price range of 39.55p to 54.06p.

Lloyds Banking currently has 63,569,225,662 shares in issue. The market capitalisation of Lloyds Banking is £32.33 billion. Lloyds Banking has a price to earnings ratio (PE ratio) of 5.92.

Lloyds Banking Share Discussion Threads

Showing 356926 to 356936 of 426450 messages
Chat Pages: Latest  14286  14285  14284  14283  14282  14281  14280  14279  14278  14277  14276  14275  Older
DateSubjectAuthorDiscuss
24/5/2021
13:03
POsullivan, on Yellowstone. I must look very American because whenever I go to Yellowstone everyone talks to me in English.
utrickytrees
24/5/2021
12:53
If anyone here is attending the Yellowstone presentation from LLOY at 2pm today it would be nice to hear your thoughts. It would also make for a pleasant diversion from some of the unhinged political, ahem, commentary that spams this board.
pdosullivan
24/5/2021
12:49
They're addicted to crystal meth Scruff, a couple of rocks in your tea in the morning & you'd pop a cap in someone's ass.
utrickytrees
24/5/2021
12:47
Lots of guns owned in the US by white rednecks.
minerve 2
24/5/2021
12:22
Got my test and trace kit. Quite neat and well designed, must cost a bob or two, and probably several tens of millions required, very profitable for someone i would think.

Made in China of course.

Slightly better than made in Hamburg I suppose, but why not made in Bradford or Pratts Bottom?

pierre oreilly
24/5/2021
12:21
Cummings is going to spew the truth soon. Knowing him as the data freak he is going to have all the evidence he needs.
minerve 2
24/5/2021
12:19
Keyboard warriors and armchair generals, you can't beat them. ;)
minerve 2
24/5/2021
12:09
ROFLMAO
what a proper clown



Remember him saying that Brexit would be reversed by the next government!!c LOLOLOL.

sentimental rules
24/5/2021
11:49
Dr Biotech is still in denial about "Ivermectin"


Interestingly update from India


The Times of India published an editorial this week signed by Dr. Vikas Sukhatme and Vidula Sukhatme, two American academics and medical professionals, suggesting a handful of cheap, commonplace drugs that could be taken as prophylactics by the most vulnerable patients in India. The drugs aren't approved to treat COVID, but nevertheless have shown "remarkable promise in preventing or treating the new coronavirus." Deploying them would likely reduce mortality and hospitalizations. While some of the drugs are currently being tested in large-scale randomized trials, there's no time to wait for the outcome.

Instead, Indian health authorities should issue guidelines recommending use of the most promising drugs for each stage of COVID-19. By so doing, physicians will be encouraged to prescribe them as interventions. The resulting data should of course be tracked for any insights it might show.

The two main drugs cited by the doctors, ivermectin and fluvoxamine, have proven effective, and anecdotal unpublished data from more than 400 acutely ill COVID-19 patients suggests that prescribing fluvoxamine and ivermectin together may be even more efficacious.

While daily case numbers have retreated from the peak in India, hospitalizations and mortality remain near all-time highs. Of course, as developing nations fight to waive IP protections for COVID vaccines, the notion that cheap existing drugs might be effective at combating COVID would represent yet another threat to Big Pharma's bottom line.

geckotheglorious
24/5/2021
11:47
If stupidity was a commodity morons like you would be rich.
madd_rip
24/5/2021
11:46
Gecko

these mindlessly angry remainiacs are quite a sad but hilarious bunch

great to see the hate frothing from their pathetic little mouths

sentimental rules
Chat Pages: Latest  14286  14285  14284  14283  14282  14281  14280  14279  14278  14277  14276  14275  Older

Your Recent History

Delayed Upgrade Clock